| |
| |
|
| Insider
Information: |
Goldfischer Carl |
| Relationship: |
Director |
| City: |
San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
49,065 |
|
|
Indirect Shares
|
2,043,293 |
|
|
| Direct
Value |
$4 |
|
|
|
Indirect Value
|
$28 |
|
|
| Total
Shares |
2,092,358 |
|
|
| Total
Value |
$32 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
| Percentage
Gain/Loss : |
 -44.2%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Poniard Pharmaceuticals |
PARD |
Director |
2011-06-09 |
39,478 |
2011-06-09 |
279,484 |
Premium* |
|
|
Map Pharmaceuticals Inc |
MAPP |
Director |
2007-10-11 |
0 |
2010-03-16 |
1,744,377 |
Premium* |
|
|
Epizyme, Inc. |
EPZM |
Director |
2022-08-12 |
0 |
2022-08-12 |
0 |
Premium* |
|
|
Cymabay Therapeutics, Inc. |
CBAY |
Director |
2019-02-07 |
0 |
2015-09-11 |
0 |
Premium* |
|
|
Galecto Inc. |
GLTO |
Director |
2020-11-02 |
9,587 |
2020-11-02 |
19,432 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| EPZM |
Epizyme, Inc. |
Director |
– • – |
2022-08-12 |
4 |
D |
$0.00 |
$0 |
I/I |
(3,380,951) |
0 |
0 |
- |
|
| EPZM |
Epizyme, Inc. |
Director |
– • – |
2022-08-12 |
4 |
D |
$0.00 |
$0 |
D/D |
(22,054) |
0 |
0 |
- |
|
| EPZM |
Epizyme, Inc. |
Director |
– • – |
2022-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
8,994 |
22,054 |
0 |
- |
|
| EPZM |
Epizyme, Inc. |
Director |
– • – |
2021-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
8,060 |
13,060 |
0 |
- |
|
| EPZM |
Epizyme, Inc. |
Director |
– • – |
2020-11-11 |
4 |
B |
$12.07 |
$60,350 |
D/D |
5,000 |
5,000 |
2.39 |
% |
|
| GLTO |
Galecto Inc. |
Director |
– • – |
2020-11-02 |
4 |
A |
$0.00 |
$0 |
D/D |
9,587 |
9,587 |
0 |
- |
|
| GLTO |
Galecto Inc. |
Director |
– • – |
2020-11-02 |
4 |
A |
$0.00 |
$0 |
I/I |
1,039,468 |
19,432 |
0 |
- |
|
| CBAY |
Cymabay Therapeutics, Inc... |
Director |
– • – |
2019-02-07 |
4 |
S |
$9.02 |
$105,328 |
D/D |
(11,675) |
0 |
0 |
- |
|
| CBAY |
Cymabay Therapeutics, Inc... |
Director |
– • – |
2019-02-07 |
4 |
OE |
$5.00 |
$63,045 |
D/D |
11,675 |
11,675 |
0 |
- |
|
| CBAY |
Cymabay Therapeutics, Inc... |
Director |
– • – |
2018-03-22 |
4 |
S |
$13.03 |
$195,375 |
D/D |
(15,000) |
0 |
0 |
- |
|
| CBAY |
Cymabay Therapeutics, Inc... |
Director |
– • – |
2018-03-22 |
4 |
OE |
$5.00 |
$77,830 |
D/D |
15,000 |
15,000 |
0 |
- |
|
| CBAY |
Cymabay Therapeutics, Inc... |
Director |
– • – |
2017-11-02 |
4 |
S |
$8.66 |
$155,880 |
D/D |
(18,000) |
0 |
0 |
- |
|
| CBAY |
Cymabay Therapeutics, Inc... |
Director |
– • – |
2017-11-02 |
4 |
OE |
$1.72 |
$42,210 |
D/D |
18,000 |
18,000 |
0 |
- |
|
| EPZM |
Epizyme, Inc. |
Director |
– • – |
2016-01-12 |
4 |
B |
$9.00 |
$4,999,995 |
I/I |
555,555 |
3,380,951 |
2.1 |
- |
|
| CBAY |
Cymabay Therapeutics, Inc... |
Director |
– • – |
2015-09-11 |
4 |
S |
$2.76 |
$42,689 |
I/I |
(15,467) |
0 |
0 |
- |
|
| CBAY |
Cymabay Therapeutics, Inc... |
Director |
– • – |
2015-09-10 |
4 |
S |
$2.71 |
$44,715 |
I/I |
(16,500) |
948 |
0 |
- |
|
| CBAY |
Cymabay Therapeutics, Inc... |
Director |
– • – |
2015-09-09 |
4 |
S |
$2.76 |
$40,743 |
I/I |
(14,762) |
1,959 |
0 |
- |
|
| EPZM |
Epizyme, Inc. |
Director |
– • – |
2014-09-04 |
4 |
S |
$35.14 |
$140,560 |
I/I |
(4,000) |
2,825,396 |
0 |
- |
|
| EPZM |
Epizyme, Inc. |
Director |
– • – |
2014-08-26 |
4 |
S |
$35.14 |
$7,027,800 |
I/I |
(200,000) |
2,825,396 |
0 |
- |
|
| EPZM |
Epizyme, Inc. |
Director |
– • – |
2014-08-25 |
4 |
S |
$35.13 |
$7,027,803 |
I/I |
(200,000) |
2,825,396 |
0 |
- |
|
| EPZM |
Epizyme, Inc. |
Director |
– • – |
2014-08-22 |
4 |
S |
$32.46 |
$4,154,765 |
I/I |
(128,000) |
3,025,396 |
0 |
- |
|
| EPZM |
Epizyme, Inc. |
Director |
– • – |
2014-08-21 |
4 |
S |
$33.04 |
$1,277,339 |
I/I |
(38,666) |
3,153,396 |
0 |
- |
|
| EPZM |
Epizyme, Inc. |
Director |
– • • |
2014-02-10 |
4 |
S |
$29.25 |
$13,650,010 |
I/I |
(466,667) |
3,192,062 |
0 |
- |
|
| CBAY |
Cymabay Therapeutics, Inc... |
Director |
– • – |
2013-10-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
46,729 |
|
- |
|
| EPZM |
Epizyme, Inc. |
Director |
– • • |
2013-06-05 |
4 |
B |
$15.00 |
$2,499,990 |
I/I |
166,666 |
3,658,729 |
2.25 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
